| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |